Urinary Incontinence: Clinical Trials

4 trials for Urinary Incontinence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 14Completed 4

Follow Urinary Incontinence: new trials by email Literature Review of Urinary Incontinence trials Research Report on Urinary Incontinence

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
Pelvic Floor Muscle Training, Mirabegron, Trospium Chloride - Urinary Bladder, Overactive, Urinary Incontinence
Early Phase 1CompletedThe University of Texas Medical Branch, Galveston482023-09-282026-06-22
Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder
Transvaginal botulinum toxin A (BTA) injection - Overactive Bladder, Bladder, Overactive
Early Phase 1CompletedStanford University152019-06-202022-07-19
IVES for Treatment of UUI and OAB
EMED detruset(TM) intravesical electrical stimulation - Urinary Bladder, Overactive, Urinary Incontinence, Urge
Early Phase 1CompletedLoma Linda University172014-12-012017-01-04
Dynamic MRI of the Behaviour of Female Pelvic Floor
movement of midurethra, bladder neck, cervix and rectum - Stress Urinary Incontinence, Genital Prolapse
Early Phase 1CompletedKuopio University Hospital742002-01-012008-09-05

Narrower conditions

Urinary Bladder, Overactive (3)  ·  Urinary Incontinence, Urge (2)  ·  Urinary Incontinence, Stress (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Lower Urinary Tract Symptoms (4)  ·  Male Urogenital Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Urination Disorders (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Urological Manifestations (4)  ·  Urinary Bladder Diseases (3)

Interventions

Injections (1)  ·  mirabegron (1)  ·  trospium chloride (1)

Sponsors

Kuopio University Hospital (1)  ·  Loma Linda University (1)  ·  Stanford University (1)  ·  The University of Texas Medical Branch, Galveston (1)

Countries

United States (3)  ·  Finland (1)

Top investigators

Amy D. Dobberfuhl, M.D. (1)  ·  Sam Siddighi, MD (1)  ·  Steve Fisher (1)

Results publications

PMID 34156506, PMID 35607890, PMID 38178267

NIH funding

R21AG081900 (1)